USPTO serial 79297103
EOBRIDGE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 28, 2021
- Examiner
- GUROK, GALINA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EOBRIDGE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable and recorded bioinformatics software for collecting, organizing, processing, analyzing, utilizing and mining data in the medical field; downloadable and recorded bioinformatics software for data analysis; Downloadable and recorded software for monitoring and controlling insulin pumps; Downloadable and recorded software for management of controllers for insulin delivery system; Downloadable and recorded software for mobile phone and smart phones, namely, application for collecting, tracking, storing and sharing medical and physiological information and data relating to diabetes management; Downloadable and recorded software for use in insulin monitoring and tracking blood glucose levels; Downloadable and recorded software for use in the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; Downloadable and recorded software for predicting blood glucose levels and controlling medicament delivery in the field of diabetes management; Downloadable and recorded software for professionals and patients for medical consultation, documentation in the nature of maintaining files and records concerning the medical condition of individuals, and providing information about diabetes via a website on the internet; Downloadable and recorded software for formatting, viewing and transmitting medical data collected and stored on blood glucose meters and insulin pumps to portable electronic devices and vice versa; Downloadable computer software for tracking and recording usage of insulin infusion sites on the body; downloadable and recorded software for database management for use in connection with the treatment of diabetes and diabetes-related data; Downloadable software for providing healthcare services, namely, for monitoring, tracking and managing patient health data and information for diabetes management purposes; Downloadable computer software for use in diabetes treatment and management; downloadable computer software for collecting biometric data from patients; Downloadable computer software for medical and diagnostic purposes, namely, for use in formatting, viewing, transmitting and transferring data from blood glucose monitors or insulin pumps to electronic data management systems such as personal computers, tablets, electronic diaries, interfaces, modems and cables for clinical medical use; Downloadable computer software for maintaining a database of blood test results from a blood glucose monitor for use by individuals with diabetes; downloadable and recorded software for data transfer, data storage and data processing of information about patient's medicinal data and levels provided by medical instruments and devices; Downloadable application software for smart phone, namely, software for monitoring and controlling insulin pumps; Downloadable application software for smart phone, namely, software for management of controllers for insulin delivery system; Downloadable application software for smart phones, namely, software for collecting, storing and transmitting patient data from insulin pumps and glucose monitors for diabetes management; Downloadable application software for smart phones, namely, software for use in monitoring and tracking insulin and blood glucose levels of diabetes patients; Downloadable application software for smart phone, namely, software for use in the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; Downloadable application software for smart phone, namely, software for predicting blood glucose levels and controlling medicament delivery in the field of diabetes management; Downloadable application software for smart phone, namely, software for professionals and patients for medical consultation, documentation in the nature of maintaining files and records concerning the medical condition of individuals, and providing information about diabetes via a website on the internet; Downloadable application software for smart phone, namely, software for formatting, viewing and transmitting medical data collected and stored on blood glucose meters and insulin pumps to portable electronic devices and vice versa; Downloadable software for smart phones for use by patients with diabetes to calculate and monitor insulin dosages; Downloadable application software for smart phones used in conjunction with blood glucose meter and insulin delivery devices for management of diabetes including, capturing, measuring, monitoring, and tracking blood glucose, predicting blood glucose levels, providing recommendations for insulin dosage requirements, and controlling medicament delivery in the field of diabetes management; downloadable application software for smart phones, namely, software for use in monitoring health and wellness; downloadable application software for smart phones, namely, software that enables healthcare professionals and patients to manage chronic disease; downloadable application software for smart phones, namely, software for communicating with a wearable injector drug delivery system and for displaying health related information; downloadable computer software for application and database integration; Downloadable and recorded medical software for monitoring and controlling insulin pumps; Downloadable and recorded medical software for controlling insulin delivery system for diabetes management; Downloadable and recorded medical software in the nature of applications for mobile phone and smart phones for collecting, storing and sharing medical information and personal medical data relating to diabetes management; Downloadable and recorded medical software for use in insulin monitoring and tracking blood glucose levels; Downloadable and recorded medical software for use in the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; Downloadable and recorded medical software for predicting blood glucose levels and controlling medicament delivery in the field of diabetes management; Downloadable and recorded medical software for professionals and patients for medical consultation, documentation in the nature of maintaining files and records concerning the medical condition of individuals, and providing information about diabetes via a website on the internet; Downloadable and recorded medical software for formatting, viewing and transmitting medical data collected and stored on blood glucose meters and insulin pumps to portable electronic devices and vice versa; downloadable and recorded medical software for providing medical and therapeutic information, nutritional information, personal training programs, medical information, and coaching in the medical field; downloadable computer software for electronic chart for medical purposes; downloadable computer software for diagnosing diseases for medical purposes; Downloadable and recorded computer software for monitoring and controlling insulin pumps; Downloadable and recorded computer software for containing information related to diabetes management for controllers for insulin delivery system; Downloadable and recorded computer software in the nature of applications for mobile phone and smart phones for collecting, tracking, storing and sharing information and personal medical data relating to diabetes management, insulin, sugar levels and the related data; Downloadable and recorded computer software for use in insulin monitoring and tracking blood glucose levels; Downloadable and recorded computer software for use in the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; Downloadable and recorded computer software for predicting blood glucose levels and controlling medicament delivery in the field of diabetes management; Downloadable and recorded computer software for professionals and patients for medical consultation, documentation in the nature of maintaining files and records concerning the medical condition of individuals, and providing information about diabetes via a website on the internet; Downloadable and recorded computer software for formatting, viewing and transmitting medical data collected and stored on blood glucose meters and insulin pumps to portable electronic devices and vice versa | ACTIVE | — |
| 010 | Drug delivery devices sold empty, namely, drug syringes; drug infusion pump; medical apparatus and instruments other than for dental purposes, namely, diabetic diagnostic medical devices, infusion pumps and insulin pumps for delivering measured amounts of drug solutions into the bloodstream over time; medical apparatus and instruments other than for dental purposes, namely, software and computer hardware for use in insulin monitoring and tracking blood glucose levels, sold as an integral component of infusion and injection devices for administering drugs and other medicaments; medical apparatus and instruments, namely, diabetic diagnostic medical devices, infusion pumps and insulin pumps for delivering measured amounts of drug solutions into the bloodstream over time; medical apparatus and instruments, namely, drug delivery devices and systems in the nature of implantable drug delivery pumps for dosing, measuring and monitoring the administration of pharmaceutical preparations; medical apparatus and instruments, namely, infusion and injection devices for administering drugs; medical apparatus and instruments, namely, injection devices for pharmaceutical preparations; medical apparatus and instruments, namely, implantable subcutaneous drug delivery devices in the nature of implantable drug delivery pumps and implantable drug delivery ports; medical apparatus and instruments for facilitating the inhalation of pharmaceutical preparations; syringes for medical purposes; insulin syringes for medical purposes; insulin pens in the nature of insulin pumps; insulin dosing devices, namely, insulin pumps and insulin injectors sold empty | ACTIVE | — |
| 042 | Research and development of medical apparatus and instruments for others; computer programming in the medical field; computer software development in the field of medical equipment; research and development of medical equipment; providing technological support services regarding medical diagnostic instruments, namely, diagnosing problems with medical equipment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EOFlow Co., Ltd.
- Other trademarks owned by EOFlow Co., Ltd.
- Other trademarks owned by EOFlow Co., Ltd.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named EOBRIDGE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 5, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 9, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 9, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 28, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 28, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 12, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 12, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 22, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 9, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 9, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 9, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 9, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 9, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 13, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 12, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 12, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 15, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 22, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 22, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 11, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 10, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 3, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 3, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 30, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 29, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |